Enzyme content and acid stability of enteric-coated pancreatic enzyme products in vitro

Pancreas

Volumn 30, Issue 2, 2005, Pages 180-183

  Case, Cheryl L ^a   Henniges, Friederike ^b   Barkin, Jamie S ^a,c  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^b Solvay Pharmaceuticals GmbH   (Germany)

^c MOUNT SINAI MEDICAL CENTER   (United States)

Author keywords

Amylase; Lipase; Pancreatic enzymes; Protease dissolution; Substitution

Indexed keywords

ACID; AMYLASE; LIPRAM CR 10; LIPRAM CR 20; LIPRAM PN 10; PANCREAS ENZYME; PANCRELIPASE; PANCRELIPASE CR 10; PANCRELIPASE CR 20; PANCRON 20; PANCRON CR 10; PROTEINASE; SOLVAY CR 10; SOLVAY CR 20; TRIACYLGLYCEROL LIPASE;

ARTICLE; DRUG CAPSULE; DRUG DETERMINATION; DRUG SOLUBILITY; ENTERIC COATED TABLET; ENZYME ACTIVITY; ENZYME ANALYSIS; PANCREAS INSUFFICIENCY; PRIORITY JOURNAL; STOMACH JUICE; STOMACH PH;

ACIDS; AMYLASES; BIOLOGICAL AVAILABILITY; ENZYME STABILITY; GASTROINTESTINAL AGENTS; HUMANS; HYDROGEN-ION CONCENTRATION; LIPASE; PANCRELIPASE; PEPTIDE HYDROLASES; PHARMACOPOEIAS; QUALITY CONTROL; TABLETS, ENTERIC-COATED; UNITED STATES;

EID: 14244268571     PISSN: 08853177     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.mpa.0000151577.91790.b1     Document Type: Article

References (8)

1. Layer P, Keller J. Pancreatic enzymes: secretion and luminal nutrient digestion in health and disease. J Clin Gastroenterol. 1999;28:3-10.
2. DiMagno EP, Go VLW, Summerskill WHJ. Relations between pancreatic enzyme outputs and malabsorption in severe pancreatic insufficiency. N Engl J Med. 1973;288:813-815.
3. Layer P, Go VLW, DiMagno EP. Fate of pancreatic enzymes during aboral small intestinal transit in humans. Am J Physiol. 1986;251:G475-G480.
4. DiMagno EP, Layer P, Clain JE. Chronic pancreatitis. In: Go VWL, DiMagno EP, Gardiner JD, Lebenthal E, Reber HA, Scheele, GA, eds. The Pancreas: Biology, Pathobiology and Disease. New York: Plenum Press; 1993:676-677.
5. DiMagno EP, Malagelada JR, Go VLW. Relationship between alcoholism and pancreatic insufficiency. Ann N Y Acad Sci. 1975;252:200-207.
6. Dutta SK, Rubin J, Harvey J. Comparative evaluation of the therapeutic efficacy of a pH-sensitive enteric-coated pancreatic enzyme preparation with conventional pancreatic enzyme therapy in the treatment of exocrine pancreatic insufficiency. Gastroenterology. 1983;84:476-482.
7. Hendeles L, Dorf A, Stedenko A, et al. Treatment failure after substitution of generic pancrelipase capsules: correlation with in-vitro lipase activity. JAMA. 1990;263:2459-2461.
8. Kraisinger M, Hochhaus G, Stecenko A, et al. Clinical pharmacology of pancreatic enzymes in patients with cystic fibrosis and in-vitro performance of microencapsulated formulations. J Clin Pharmacol. 1994;34:158-166.